Could the Immune System Meddle with the Efficacy of Cancer Biologics?
ADAs Are Not a Problem—Yet
Reactivating a Dormant X
A New Strategy to Treat Rett Syndrome, which Occurs Almost Exclusively in Girls
Polygenic Risk Scores Show Utility for Stratifying Disease Risk
Polygenic Risk Scores Offer a Glimpse of True Clinical Utility
Tumor Biomarkers Culled from Errant Transcripts
Potential for Blood Platelet–Derived Biomarkers to ID and Locate Tumors
For full access to this article login to GEN Select now.
Biomanufacturers Confront Big Data Issues
Superior Data Management Essential to Achieving Operational Efficiencies
- Bioprocessing is a major growth industry within the life sciences. But why is this cell growth industry emerging so quickly? The rise in large molecule therapeutics, vaccines, and biosimilars has been rapid, but the FDA has fed the sector with its Quality by Design (QbD) requirements backed up ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.